AI hunts new uses for Phase 3 metabolic drug
THPharm already has a drug in late-stage trials. Now it’s using AI to work backwards and find out…
Eli Lilly and Insilico Medicine forge $2.75bn AI-driven R&D pact
Eli Lilly is joining forces with artificial intelligence (AI)-powered biotech, Insilico Medicine, in a drug discovery and development…